Regulatory alerts roundup

CBD-Intel regulatory news in brief, 2nd-9th April

Written by CBD-Intel || 9th April 2021 || Regulatory alerts roundup | Regulation and Legislation | Geographies: Europe

This week's regulatory news in brief includes updates from Czech Republic, Belgium, the UK, Mexico and the US ...

Restricted content. Do you want to read more?

Subscribers: Login here

Featured topic

The Food and Drug Administration (FDA) rejected applications to use hemp extract as a dietary supplement.

Here are the conclusions we have attracted. CBD-Intel will continue to work on providing answers to the various questions that have arisen.

Blog | Policy and politics | US federal regulation